Pradžia › Neuromuskuliniai sutrikimai › Kalifornija
Neuromuskuliniai sutrikimai klinikiniai tyrimai Kalifornija
6 tyrimai dėl Neuromuskuliniai sutrikimai ieško dalyvių vietose Kalifornija.
Oficialus tyrimo tekstas (anglų kalba)
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
Renkami dalyviai1 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-15 · NCT06916806A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- University of California, Irvine (UCI), Irvine
- Stanford Neuroscience Health Center, Palo Alto
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-20 · NCT07282847Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
- University of California, Davis, Sacramento
Renkami dalyviai
Amžius nuo 22 iki 75 · Visoms lytims · Atnaujinta 2026-04-14 · NCT07357428Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
- Stanford University, Palo Alto
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 5 ir vyresni · Visoms lytims · Atnaujinta 2026-04-09 · NCT06839469Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2022-04-29 · NCT04684602Congenital Muscle Disease Study of Patient and Family Reported Medical Information
- Congenital Muscle Disease International Registry (www.cmdir.org), Lakewood
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2021-08-09 · NCT01403402Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.